Abstract:Up to 15% of patients with essential hypertension have inappropriate regulation of aldosterone; although only a minority have distinct adrenal tumors, recent evidence shows that mineralocorticoid receptor activation contributes to the age-related blood pressure rise and illustrates the importance of aldosterone in determining cardiovascular risk. Aldosterone also has a major role in progression and outcome of ischemic heart disease. These data highlight the need to understand better the regulation of aldosterone synthesis and its action. Aldosterone effects are mediated mainly through classical nuclear receptors that alter gene transcription. In classic epithelial target tissues, signaling mechanisms are relatively well defined. However, aldosterone has major effects in nonepithelial tissues that include increased synthesis of proinflammatory molecules and reactive oxygen species; it remains unclear how these effects are controlled and how receptor specificity is maintained. Variation in aldosterone production reflects interaction of genetic and environmental factors. Although the environmental factors are well understood, the genetic control of aldosterone synthesis is still the subject of debate. Aldosterone synthase (encoded by the CYP11B2 gene) controls conversion of deoxycorticosterone to aldosterone. Polymorphic variation in CYP11B2 is associated with increased risk of hypertension, but the molecular mechanism that accounts for this is not known. Altered 11beta-hydroxylase efficiency (conversion of deoxycortisol to cortisol) as a consequence of variation in the neighboring gene (CYP11B1) may be important in contributing to altered control of aldosterone synthesis, so that the risk of hypertension may reflect a digenic effect, a concept that is discussed further. There is evidence that a long-term increase in aldosterone production from early life is determined by an interaction of genetic and environmental factors, leading to the eventual phenotypes of aldosterone-associated hypertension and cardiovascular damage in middle age and beyond. The importance of aldosterone has generated interest in its therapeutic modulation. Disadvantages associated with spironolactone (altered libido, gynecomastia) have led to a search for alternative mineralocorticoid receptor antagonists. Of these, eplerenone has been shown to reduce cardiovascular risk after myocardial infarction. The benefits and disadvantages of this therapeutic approach are discussed.

Volume-pressure relationships during development of mineralocorticoid hypertension in man

Volume overload is a major characteristic in primary aldosteronism: a 3-year follow-up study

A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function

Relationship between blood pressure and renin, angiotensin II and atrial natriuretic factor after renal transplantation

Spooky sodium balance

Endothelin-1 and adrenomedullin plasma levels after exposure to fludrocortisone, dexamethasone, and spironolactone

Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney disease

Effects of Spironolactone on Dialysis Patients with Refractory Hypertension: a Randomized Controlled Study.

The role of atrial natriuretic factor [alpha-human ANF-(99-126)] in the hormonal and renal adaptation to sodium deficiency.

Adaptation to chronic potassium loading in normal man

Sodium loading in ambulatory patients with heart failure with reduced ejection fraction: Mechanistic insights into sodium handling

Observations on the Use and Limitations of Renal Vein Renins in Hypertensive Patients

Sodium Excretion and Sympathetic Activity in Relation to Severity of Hypertension

Pressure natriuresis and the renal control of arterial blood pressure

Effects of Acute Haemodialysis-Induced Changes in Sodium Balance upon Experimentally Hypertensive Rats

The Spectrum of Dysregulated Aldosterone Production: An International Human Physiology Study

Blood pressure regulation in end-stage renal disease and anephric man

Abstract MP70: Aldosterone and Inverse Salt Sensitivity of Blood Pressure

High-dose angiotensin-converting enzyme inhibition restores body fluid homeostasis in heart-transplant recipients

Apparent mineralocorticoid excess and the long term treatment of genetic hypertension

Hemodynamic Mechanisms Initiating Salt-Sensitive Hypertension in Rat Model of Primary Aldosteronism